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Background: Staphylococcus aureus is commonly isolated from infected wounds both in animals and humans. It is
known to be an excellent biofilm former and biofilms are present in as many as 60% of chronic wounds. Despite that the
presence of biofilms in infections are common, antiseptics are usually qualified for in vivo testing according to their effect
on planktonic cells. As it is well known that bacteria in biofilms are more tolerant to antiseptics than planktonic bacteria,
biofilm infections can be difficult to treat. The aim of the study was to compare three different categories of antiseptics,
biguanide (chlorhexidine), quaternary ammonium compound (QAC; Pyrisept) and iodine/iodophores (2% iodine liniment),
with regards to efficacy in killing S. aureus in biofilm. If there was observed a difference in efficacy between these
antiseptics, a second aim was to find the most effective of the three antiseptics.
Results: Large differences in the bactericidal effect of the different antiseptics against S. aureus in biofilm were observed
in the present study. Iodine treatment was found to be the most effective followed by Pyrisept and chlorhexidine.
Conclusions: The bactericidal effect of the different antiseptics used in the present study was found to vary significantly
against S. aureus in biofilm. The present study gives valuable knowledge with regards to selecting the antiseptics that are
most likely to be successful in treating biofilm infected wounds. This study also contributes to focus attention on the
importance of qualifying antiseptics based on results using biofilm bacteria rather than planktonic bacteria.
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In most natural environments, including in clinical in-
fections, bacteria form biofilm by encasing themselves in
a self-produced extracellular protective matrix [1,2]. The
understanding of the clinical importance of biofilm in
wounds is relatively new. By using advanced microscopy
it was demonstrated that as many as 30 of 50 chronic
wounds harbored biofilms [3]. Chronic wounds can be
colonized with several different microorganisms of
which Staphylococcus aureus is the most commonly iso-
lated bacterial species [4-6]. S. aureus is known to be an
excellent biofilm former and is also found to be able to
form biofilm in wounds [3].
A biocide is a general term of describing chemical
agents that inactivate microorganisms. Antiseptics are de-
fined as biocides that either destroy or inhibit the growth
of microorganisms in or on living tissue. Antiseptics are* Correspondence: lene.vestby@vetinst.no
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unless otherwise stated.generally qualified for in vivo testing according to their ef-
fect on planktonic bacteria although it is well known that
bacteria in biofilms are more tolerant to antiseptics than
planktonic bacteria, thus making infections harboring bio-
films difficult to treat [2]. Several different categories of
antiseptics are in use in wound care, including biguanide,
quaternary ammonium compounds (QACs) and iodine/
iodophores [7]. The working actions of antiseptics are dif-
ferent and for antiseptics like iodine/iodophores, the exact
mode of action is still unknown [7]. For other antiseptics
like QACs and biguanides, the modes of action are more
documented. In general, QACs acts by binding to the bac-
terial cell membrane with the cationic group facing out-
wards. The hydrophobic tails are inserted into the lipid
bilayer and cause disruption and leakage of cellular con-
tent [7,8]. Biguanides have a working action by absorption
to the cell membrane by electrostatic interaction [9].
In the present study, three different non-prescriptive
antiseptics that are commonly used in animal and hu-
man wound care were tested against S. aureus in biofilm.
The aim of the study was to compare these threentral. This is an Open Access article distributed under the terms of the Creative
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biofilm. If there was observed a difference in efficacy be-
tween these antiseptics, a second aim was to find the
most effective of the three antiseptics.
Methods
Bacterial strains and culture conditions
Three wild-type strains of S. aureus with Norwegian
Veterinary Institute biobank strain identification numbers
1378–1, 300–1 and 132–323 of animal origin were used.
The strains were stored at – 70°C in Brain Hearth Infusion
broth (BHI; Difco, BD, NJ, USA) supplemented with 15%
glycerine (Merck KGaA, Darmstadt, Germany) and recov-
ered on blood agar at 37 ± 1°C overnight (18–24 h).
Antiseptics
Pyrisept (solution 1 mg/ml cetylpyridinklorid; Weifa,
Oslo, Norway), chlorhexidine (chlorhexidine diacetate
1 mg/ml; Fresenius Kabi, Halden, Norway) and iodine
(2% liniment NAF: Iodine 2 g/ml, Potassium iodine
1.4 g/ml, ethanol 96%; A/S Den norske Eterfabrikk, Oslo,
Norway) were used. The iodine liniment contained 96%
ethanol and to test the possible effect of this ethanol on
S. aureus in biofilm, 96% ethanol (Kemetyl Norge AS,
Vestby, Norway) was tested in the biofilm experiment, in
addition to the antiseptics.
Susceptibility test
To verify that the bacterial strains used in the experiment
were susceptible for the antiseptics tested, single colonies
from a fresh overnight cultures on blood agar were picked
and transferred into sterile saline to McFarland 0.5 and
the suspension was spread on blood agar using an auto-
mated plate spreader. Aliquots of 10 μl of each of the
three antiseptics and ethanol were added to separate blank
6 mm paper discs (BD, Sparks, MD, USA) that were
placed on top of the agar. Sterile saline was used as a con-
trol. Ethanol (96%) was not found possible to evaluate in
this system as absolute ethanol is volatile and evaporated
quickly from the discs. Agar plates were incubated at 37°C
overnight before zone diameters were measured using a
ruler. The experiment was performed three times.
Biofilm experiments
To create an overnight culture in broth, a single colony
were picked from the overnight culture on blood agar and
transferred into Trypticase Soy Broth (TSB; Oxoid Ltd,
Hampshire, England) and incubated statically at 37°C over-
night. Biofilms were grown on autoclaved microscope slides
(76 x 26 mm, Menzel GmbH + CoKG, Braunschweig,
Germany) using overnight culture in TSB supplemented
with 1% glucose and 1% NaCl (TSB 1 + 1) in the ratio 1:100
and incubated statically at 37°C for 24 h. After incubation,
the biofilm were washed three times in sterile saline toremove loosely adhered bacteria. To simulate a “flushing of
wound” procedure, the biofilms were submerged in antisep-
tic, ethanol or saline solution for 3 sec followed by drying
in room temperature for 10 min. Thereafter, the micro-
scope slides were submerged in Dey Engley Neutralizing
broth (Difco). Subsequently the microscope slides were
washed in saline solution before the biofilms were removed
by scraping with a sterile cell scraper (BD Falcon, Bedford,
MA, USA) and transferred to sterile reagent tubes contain-
ing 5 ml sterile saline and 20 glass beads (3 mm; Assistent,
Glaswarenfabrik Karl Hecht GmbH & Co KG, Bavaria,
Germany). The tubes were vortexed at 2000 rpm for one
minute and the solution was serial diluted in sterile saline,
plated onto blood agar and recovered at 37°C for 24 h.
After incubation, the number of colony forming units (cfu)
was counted. All experiments were performed three times.
Statistics
Statistical analyses were performed using JMP version
9.0.0 (SAS Institute, Cary, NC, USA) and the non-
parametric Wilcoxon/ Kruskal-Wallis test was used to
calculate significance. The level of significance was set to
P < 0.05 in all experiments.
Results
Distinct growth inhibition zones were seen for all three
antiseptics, indicating that the bacterial strains used
were susceptible for all antiseptics used in the experi-
ments. Although all antiseptics showed inhibition zones,
significant differences were found in inhibition zones
diameter between all antiseptics (P = 0.027) (Figure 1).
Large differences in the bactericidal effect of the differ-
ent antiseptics against S. aureus in biofilm were ob-
served in this study (Figure 2). Iodine treatment was
found to be the most effective as no colony forming
units (cfu) was detected after treatment (P = 0.037). Treat-
ment with sterile saline was used as a control and showed
that the average number of cfu in the biofilm was 1.0x108.
Exposure to 96% ethanol was the second most effective
treatment as the average number of recovered bacteria
from the biofilm were reduced by 2.3 log10 from the con-
trol (P = 0.049). Treatment with Pyrisept resulted in a 0.7
log10 reduction from the control (P = 0.049). Treatment
with chlorhexidine was not found significant with 0.2
log10 (P = 0.126) reduction from the control.
Results showed that the bactericidal effect of 96%
ethanol is significantly less than that of 2% iodine lini-
ment containing 96% ethanol (P = 0.037).
Discussion
Striking differences in the bactericidal effect of the differ-
ent antiseptics against S. aureus in biofilm were observed
in this study. Interestingly, the observed differences were
not fully correlated to differences in bactericidal effect on
Figure 1 Inhibition zone diameter. Mean inhibition zone diameter in millimeter for each antiseptic used in the experiment. The results are
presented with standard deviation. Levels not connected by the same letter are significantly different (P <0.05).
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Pyrisept in the biofilm experiments, but gave larger inhib-
ition zones of planktonic growth on agar. One likely hy-
pothesis that could explain for the differences in effect
against S. aureus in biofilm could be that the three differ-
ent antiseptics have different permeability through the
extracellular matrix and/or that the antiseptics contain
components that react with the matrix. This could subse-
quently give large differences in effect against S. aureus in
biofilm as observed in this study.
Pyrisept contains the active ingredient cetylpyridinum
chloride, which is a cationic quaternary ammonium









































Figure 2 Effect of antiseptics against Staphylococcus aureus in biofilm in vit
Results are presented with standards deviation. Iodine treatment gave no r
Bars marked with “*” shows treatments with significant reduction compareagent with antibacterial activity by binding to the cell
membrane [7,8,10]. Cetylpyridinum chloride is known to
be effective against Gram positive bacteria but the effect
is reduced in the presence of organic compounds [7].
This may explain the poor efficacy against S. aureus in
biofilm as biofilm matrix contains organic materials such
as proteins [11]. Chlorhexidine, which is a biguanide,
showed practically no bactericidal effect on S. aureus in
biofilm, in the present study. Other studies have found bet-
ter result using chlorhexidine by prolonging the contact
time up to 15 min [9,12]. The antibacterial action of chlor-
hexidine is by adsorption to the cell membrane [9]. The fact
that both cetylpyridinum chloride and chlorhexidine actyrisept Chlorhexidine Iodine
*
*
ro. Bars represent mean log10 recovered bacteria after treatment.
ecovered bacteria after treatment in any of the experiments.
d to the control (P <0.05).
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ported to have reduced efficacy in the presence of organic
material supports our results of being non-efficient against
S. aureus in biofilm.
Although the exact antimicrobial action of iodine is un-
known, it has been suggested that the working action of
iodine is that it attacks key groups of proteins, nucleotides
and fatty acids which results in cell death [7]. Proteins and
nucleotides are key components of the extracellular pro-
tective matrix of S. aureus [13]. An attack on these matrix
components by iodine may result in disruption of the
matrix, leaving the bacterial cells less protected against the
bactericide. This may explain why it displays a more effi-
cient antiseptic action against biofilm bacteria than cell
surface active antiseptics such as QAC’s and chlorhexi-
dine. In addition to iodine compounds, 2% iodine liniment
also contains 96% ethanol. The antibacterial effect of etha-
nol is well known [7] and needed to be tested in this study
as it may be the causing or contributing factor to the good
results observed for iodine liniment. The use of 96% etha-
nol in the present study showed that ethanol definitely has
a bactericidal effect on S. aureus in biofilm but the iodine
treatment is far more effective than ethanol alone. Ethanol
and ethanol containing disinfectants has previously been
shown to be very effective against bacteria in biofilm [14].
The observed effect of ethanol in the present study com-
pared to the study by Moretro et al. [14] is far less and
reasons for this might be that ethanol is more effective
against Salmonella than S. aureus, in general or when in
biofilm. The contact time is longer in the study by More-
tro et al. [14] than in the present study and can also ex-
plain the conflicting results. Interestingly, the antibacterial
effect of ethanol has been shown to be almost identical to
iodine by denaturing proteins [7]. For this reason, it is
likely that both iodine and ethanol together contribute to
the exceptionally good results obtained by 2% iodine lini-
ment in this study. The exact mode of action of 2% iodine
against S. aureus in biofilm should be explored further as
this is important knowledge with regards to selecting the
antiseptics that are most likely to be successful in treating
infected wounds harboring biofilms.
In our study, we submerged the pre-formed biofilms
in antiseptics for 3 sec and then the biofilms were re-
moved from the antiseptic solution and dried in room
temperature for 10 minutes. This was to simulate a
“flushing of a wound” procedure. It is recommended that
a modular approach be taken to first test the formula-
tion in vitro, then proceed to in vivo testing if the
in vitro testing is successful. In this in vitro model, we
used sterile microscope slides as a basis for S. aureus to
form biofilm. The reason for selecting these conditions
was to study the isolated effect of the antiseptics on bac-
teria in biofilm. In vivo in wounds, a large number of
additional factors will be present that may influence theeffects of the antiseptics. However, if an antiseptic has
little or no effect in our system, it will most likely be
even less effective under the more challenging condi-
tions in vivo.
Conclusions
The bactericidal effect of the different antiseptics used in
the present study was found to vary significantly against
S. aureus in biofilm. Treatment with 2% iodine liniment
was found to eradicate S. aureus in biofilm in vitro
whilst chlorhexidine and Pyrisept showed less bacteri-
cidal effect. For this reason, the present study indicates
that iodine might be the best choice of the three antisep-
tics tested for use against S. aureus in biofilm. The
present study also contributes to focus attention on the
importance of qualifying antiseptics based on results
using biofilm bacteria rather than planktonic bacteria.
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